IL1B and type 2 diabetes mellitus: Increasing appreciation places adipose tissue as an immunometabolic organ; thus, its dysfunction in states of obesity and T2D most likely enhances NLRP3 inflammasome-mediated secretion of IL-1β to decrease insulin sensitivity (Söderbom and Zeng 2020).